广生堂：一类广谱抗新冠口服小分子创新药GST-HG171片Ⅰ期临床试验首例受试者成功入组

array(1) { [444598]=> array(2) { [2]=> array(3) { [0]=> string(12) "临床试验" [1]=> string(9) "广生堂" [2]=> string(12) "新冠疫情" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }